Donor-derived natural killer cell infusion

donor-derived natural killer cells · Federal Research Institute of Pediatric Hematology, Oncology and Immunology

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Donor-derived natural killer cell infusion, covering 2014-04-24 to 2025-12-01. Get the full timeline:

Most recent: Clinical Trial Update: Feasibility and Safety of Donor-derived NK-cell Infusions for Leukemia Relapse Prophylaxis After Hematopoietic Stem Cell Transplantation [Phase 2]

See pricing